August 25, 2022
Gilead Sciences Inc. is on the hook for $2 million after backing out of a contract for an eight-part documentary series on HIV, since its sponsorship deal had a clear deadline for payment that the pharmaceutical company missed, a Pennsylvania federal judge said.